Proveris Scientific Appoints Zachary Pitluk Vice President of Commercialization

MARLBOROUGH, Mass.--Proveris Scientific Corporation announced today the appointment of Zachary Pitluk, PhD as Vice President of Commercialization. Dr. Pitluk will apply more than a decade of proven expertise in driving forth the business development and commercialization strategies of global life sciences organizations to define and develop Proveris’s commercial vision and expand its global footprint.

“I am excited to join this dedicated team of people who are successfully carrying out a collective mission to improve the safety and quality of spray therapies,” said Zachary Pitluk, Vice President of Commercialization, Proveris Scientific Corporation. “The Company’s patented testing design methodology, equipment and ‘on-demand’ Viota^® software are also enabling organizations to significantly trim the development timelines for aerosol drug delivery projects. Proveris is truly transforming the industry—I welcome the opportunity to participate in that distinct effort.”

Prior to joining Proveris, Dr. Pitluk was Vice President of Business Development at biosimulation leader Gene Network Sciences, where he directed the Company’s market development, commercialization, CRM and sales efforts. Previously, he served as Business Manager North America Life Sciences at Definiens, AG, in which role he grew the division’s revenue by 36 fold. Prior to that, Dr. Pitluk held several sales and business development positions at Cellomics.

“The combination of Zach’s technical knowledge and proven proficiency in commercial development provides a depth of experience that is highly relevant to the goals of our company,” said Dino J. Farina, president of Proveris Scientific Corporation. “We are fortunate to be able to bring someone aboard with Zach’s unique qualifications. His appointment undeniably positions us to better communicate the Company’s value to the market and capture new revenue opportunities.”

Dr. Pitluk earned a PhD in Molecular Biophysics and Biochemistry from Yale University and a BSc in Biochemistry from the University of Illinois.

About Proveris

Proveris accelerates the success of nasal and aerosol drug developers by providing a proven testing process, patented equipment, and a patented software platform that unifies all test methods, data and analysis. Leading pharmaceutical companies around the world turn to Proveris for the expertise required to tackle the challenges of developing safe, effective and innovative spray therapies. Proveris’s proven track record of dedication to customer success has made it the company pharmaceutical developers and the FDA rely on for software, equipment, protocols and support for test regimes that bring next-generation spray-delivered drugs to market faster and more efficiently than ever before. The privately-held company is ISO9001:2000 certified and headquartered in Marlborough, Mass., USA. For additional information about Proveris’ Viota software platform and equipment, please visit http://www.proverisscientific.com, call (508) 460-8822, or email info@proverisscientific.com.